Stock futures were rising Monday ahead of a week filled with earnings reports, including quarterly updates from Tesla and Alphabet, and as Wall Street monitored the latest trade developments.

These stocks were poised to make moves Monday:

Tesla gained 1.6% in premarket trading. CEO Elon Musk issued a tweet Saturday that he was, “Back to working 7 days a week and sleeping in the office if my little kids are away,” which will come as good news to investors in the electric-vehicle maker with Tesla set to reportquarterly earningsWednesday and the stock down 18% this year. Wall Street expects Tesla to earn 43 cents a share on an adjusted basis in the second quarter, down from 53 cents a year earlier.

Block was rising 9.2% after it was announced Friday that the financial technology company formerly known as Square would be joining the S&P 500 before the start of trading Wednesday. Block will replace Hess following Chevron’s purchase of the energy company on Friday. Robinhood Markets and AppLovin, both prime candidates for admission into the benchmark index, were up 0.4% and down 0.4%, respectively, in premarket trading.

Opendoor Technologies shares jumped another 20% in premarket trading on Monday. The digital real estate platform has recently exploded in popularity among retail investors, as its stock has jumped 189% last week.

Crypto stocks jumped in premarket trading on Monday. Upexi rose 16%; SharpLink Gaming rose 12%; BTCS rose 11%; GameSquare, BitMine Immersion Technologies, and Sequans Communications rose 5%; Circle, Strategy, and Coinbase rose 2%.

Sarepta Therapeutics was down 3.4% in premarket trading after tumbling 36% on Friday. The company issued a statement late Friday after stock markets closed that said it would “continue to ship Elevidys to the ambulant population,” following a request from the Food and Drug Administration to stop shipments of the Duchenne muscular dystrophy gene therapy. Sarepta said there was ”no new data to suggest it is dangerous to the patient population currently using it.” Two patients died earlier this year after taking the drug, and Sarepta already had paused shipments of Elevidys to a subset of patients with more advanced disease. Early Friday, CEO Doug Ingram acknowledged he hadn’t disclosed the recent death of a patient in a trial of a different gene therapy while rolling out a major restructuring late Wednesday that included staff cuts and a trimming of its pipeline.

Stellantis said on Monday it expected the hit from restructuring costs and the initial impact of U.S. tariffs to have pushed the carmaker to a 2.3 billion euro ($2.7 billion) loss in the first half of the year. The shares dropped 2.1% in premarket trading.

Alaska Air was up 1.2%. The carrier temporarily grounded its fleet late Sunday following an IT outage. Alaska didn’t specify the cause of the disruptions. The rounding appeared to have minimal impact and has since been resolved.

Ryanair Holdings shares jumped 6.4% in premarket trading. Ryanair Holdings Plc net income in the first quarter more than doubled, and the budget airline said it will recover most of the fare drop suffered last year to achieve “reasonable” profit growth in fiscal 2026.

Earnings reports are expected Monday from Verizon Communications, NXP Semiconductors, Steel Dynamics, Domino’s Pizza, and Cleveland-Cliffs.

Verizon was up 0.7% in premarket trading ahead of second-quarter earnings from the telecommunications giant. Analysts expect Verizon to post adjusted profit of $1.19 a share on revenue of $33.72 billion.

Reports are expected later in the week from Alphabet, Tesla, International Business Machines, Intel, SAP, Coca-Cola, T-Mobile, AT&T, ServiceNow, Philip Morris International, RTX, Texas Instruments, Lockheed Martin, Capital One Financial, Sherwin-Williams, General Motors, D.R. Horton, NextEra Energy, GE Vernova, Chipotle Mexican Grill, Honeywell, Union Pacific, Newmont, Charter Communications, and Phillips 66.